Using Predictive Intelligence to Uncover the Rare Disease Patient Journey
In this podcast interview, Dan Fisher, managing director and practice lead for IPM.ai, explains the...
2023 Survey: Automation Is Ubiquitous for Orphan and Specialty Drug Commercialization
87% of Biopharma Respondents Use AI/ML for Post-Market Activities, But Key Missed Opportunities...
How Real World Data Revealed the Need for Broad HCP Education of Frontotemporal Dementia
By: Dan Fisher, Principal, IPM.ai
Accelerating Trial Recruitment by Identifying HCPs with a Diverse and Addressable Patient Population
By: Nitin Choudhary, EVP & GM, IPM.ai
IPM.ai Expands Its Data Universe with Specialty Pharmacy and Payer Master Enhancements
By: Nitin Choudhary, EVP & GM, IPM.ai
Using ML/AI to Find the Right Patients at the Right Time: A Conversation with AVEO Oncology
By: Dan Fisher, Principal, IPM.ai
Ganesh Rajaratnam, Senior Director of Commercial Operations,...
IPM.ai Recognized as One of the World’s Most Innovative Companies in 2022 by Fast Company
IPM.ai’s transformative approach to patient-finding for specialty and rare conditions captures the...
Ron Elwell, CEO and Founder of IPM.ai Wins MM+M’s Pinnacle Award
By: Dan Fisher, Principal, IPM.ai
Ron Elwell, CEO and founder of IPM.ai is a proud recipient of ...